Reducing Hereditary Cancer Act
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Reducing Hereditary Cancer Act
This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 4752: Reducing Hereditary Cancer Act. 119th Congress. Open America. https://openamerica.io/bill/119-HR-4752/
"H.R. 4752: Reducing Hereditary Cancer Act." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-HR-4752/.
H.R. 4752, 119th Cong. (2026), https://openamerica.io/bill/119-HR-4752/.
[H.R. 4752: Reducing Hereditary Cancer Act](https://openamerica.io/bill/119-HR-4752/)